Results 271 to 280 of about 55,676 (335)
Interferon-gamma signaling pathway: Modulation of key genes in the progression of glioblastoma. [PDF]
World J Biol ChemOropeza-Martínez E +6 more
europepmc +1 more source
Identification of two tyrosine kinase like proteins as important modulators of the STATc-mediated response to hyperosmolarity [PDF]
, 2013 Vu, Linh Hai
core
Clinical and laboratory presentations of Janus Kinase II-positive patients in Saudi population
, 2014 Hafiz Malhan +5 more
openalex +1 more source
International Journal of Dermatology, EarlyView.ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant physical and psychosocial burden. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has proven to be effective for moderate‐to‐severe AD, but long‐term real‐world data remain limited.
Francesco Leo +11 more
wiley +1 more source
Initial solid tumor testing (stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program. [PDF]
Pediatr Blood Cancer, 2014 Houghton PJ +10 more
europepmc +1 more source
Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung. [PDF]
PharmaceuticsWang D +7 more
europepmc +1 more source
Tissue Resident Memory Cells: Friend or Foe?
Immunology, EarlyView.Tissue‐resident memory T cells (TRM cells) are specialised immune cells in barrier tissues like the lungs, skin and gut, providing rapid host defence and tumour surveillance. Their retention and differentiation are regulated by molecules such as CD69, CD103 and TGF‐β. Dysregulation of TRM cells can lead to chronic activation, driving conditions such as
Chidimma F. Chude +2 more
wiley +1 more source
Diversifying the triquinazine scaffold of a Janus kinase inhibitor. [PDF]
RSC Med ChemMulliri K +5 more
europepmc +1 more source